Human anelloviruses and the central nervous system

Reviews in Medical Virology

Volumn 20, Issue 6, 2010, Pages 392-407

  Maggi, Fabrizio ^a   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOCAPSID PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ANELLOVIRUS; AUTOPSY; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHRONIC HEPATITIS; HUMAN; IMMUNE RESPONSE; MICROBIAL DIVERSITY; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENETIC TREE; PREVALENCE; PROTEIN DOMAIN; REVIEW; TAXONOMY; TORQUE TENO VIRUS; VIREMIA; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS TRANSMISSION;

ANELLOVIRUS; BRAIN; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROSPINAL FLUID; DNA VIRUS INFECTIONS; HUMANS;

EID: 77958531364     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.668     Document Type: Review

References (131)

1. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in post-transfusion hepatitis of unknown etiology. Biochemical and Biophysical Research Communications 1997; 241: 92-97.
2. Okamoto H, Nishizawa T, Kato N, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with post-transfusion hepatitis of unknown etiology. Hepatology Research 1998; 10: 1-16.
3. Okamoto H. History of discoveries and pathogenicity of TT viruses. Current Topics in Microbiology and Immunology 2009; 331: 1-20.
4. Okamoto H. TT viruses in animals. Current Topics in Microbiology and Immunology 2009; 331: 35-52.
5. ICTV. Current virus taxonomy. Available at: 2009.
6. Hino S. TTV, a new human virus with single stranded circular DNA genome. Reviews in Medical Virology 2002; 12: 151-158.
7. Biagini P. Classification of TTV and related viruses (anelloviruses). Current Topics in Microbiology and Immunology 2009; 331: 21-33.
8. Takahashi K, Iwasa Y, Hijikata M, Mishiro S. Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Archives of Virology 2000; 145: 979-993.
9. Ninomiya M, Nishizawa T, Takahashi M, Lorenzo FR, Shimosegawa T, Okamoto H. Identification and genomic characterization of a novel human Torque teno virus of 3.2 kilobases. Journal of General Virology 2007; 88: 1939-1944.
10. Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. Journal of Virology 2005; 79: 8230-8236.
11. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (eds). Virus Taxonomy. Elsevier Academic press: London, 2005.
12. Mushahwar IK, Erker JC, Muerhoff AS, et al. Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 3177-3182.
13. Itoh Y, Takahashi M, Fukuda M, et al. Visualization of TT virus particles recovered from the sera and feces of infected humans. Biochemical and Biophysical Research Communications 2000; 279: 718-724.
14. Miyata H, Tsunoda H, Kazi A, et al. Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. Journal of Virology 1999; 73: 3582-3586.
15. Erker JC, Leary TP, Desai SM, Chalmers ML, Mushahwar IK. Analyses of TT virus full-length genomic sequences. Journal of General Virology 1999; 80: 1743-1750.
16. Hijikata M, Takahashi K, Mishiro S. Complete circular DNA genome of a TT virus variant (isolate name SANBAN) and 44 partial ORF2 sequences implicating a great degree of diversity beyond genotypes. Virology 1999; 260: 17-22.
17. Peters MA, Jackson DC, Crabb BS, Browning GF. Chicken anemia virus VP2 is a novel dual specificity protein phosphatase. The Journal of Biological and Chemistry 2002; 277: 39566-39573.
18. Bendinelli M, Pistello M, Maggi F, Fornai C, Freer G, Vatteroni ML. Molecular properties, biology and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clinical Microbiology Reviews 2001; 14: 98-113.
19. Kakkola L, Hedman K, Qiu J, Pintel D, Soderlund-Venermo M. Replication of and preotein synthesis by TT viruses. Current Topics in Microbiology and Immunology 2009; 331: 53-64.
20. Nishizawa T, Okamoto H, Tsuda F, et al. Quasispecies of TT virus (TTV) with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infections. Journal of Virology 1999; 73: 9604-9608.
21. Okamoto H, Nishizawa T, Ukita M. A novel unenveloped DNA virus (TT virus) associated with acute and chronic non-A to G hepatitis. Intervirology 1999; 42: 196-204.
22. Mariscal LF, Lopez-Alcorocho JM, Rodriguez-Inigo E, et al. TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells. Virology 2002; 301: 121-129.
23. Handa A, Dickstein B, Young NS, Brown KE. Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion 2000; 40: 245-251.
24. Tawara A, Akahane Y, Takahashi M, Nishizawa T, Ishikawa T, Okamoto H. Transmission of human TT virus of genotype 1a to chimpanzees with fecal supernatant or serum from patients with acute TTV infection. Biochemical and Biophysical Research Communications 2000; 278: 470-476.
25. Ott C, Duret L, Chemin I, Trepò C, Mandrand B, Komurian-Pradel F. Use of a TT virus ORF1 recombinant protein to detect anti-TT virus antibodies in human sera. The Journal of General Virology 2000; 81: 2949-2958.
26. Tsuda F, Takahashi M, Nishizawa T, et al. IgM-class antibodies to TT virus (TTV) in patients with acute TTV infection. Hepatology Research 2001; 19: 1-11.
27. Gergely P Jr, Pullmann R, Stancato C, et al. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clinical Immunology 2005; 116: 124-134.
28. Kakkola L, Bonden H, Hedman L, et al. Expression of all six Torque teno virus (TTV) proteins in bacteria and in insect cells, and analysis of their IgG responses. Virology 2008; 382: 182-189.
29. Itoh K, Takahashi M, Ukita M, Nishizawa T, Okamoto H. Influence of primers on the detection of TT virus DNA by polymerase chain reaction. The Journal of Infectious Diseases 1999; 180: 1750-1751.
30. Moen EM, Sleboda J, Grinde B. Real-time PCR methods for independent quantitation of TTV and TLMV. Journal of Virological Methods 2002; 104: 59-67.
31. Koidl C, Michael B, Berg J, et al. Detection of transfusion transmitted virus DNA by a real-time PCR. Journal of Clinical Virology 2004; 29: 277-281.
32. Devalle S, Niel C. A multiplex PCR assay able to simultaneously detect Torque teno virus isolates from phylogenetic groups 1 to 5. Brazilian Journal of Medical and Biological Research 2005; 38: 853-860.
33. Haramoto E, Katayama H, Ohgaki S. Quantification and genotyping of torque teno virus at a wastewater treatment plant in Japan. Applied and Environmental Microbiology 2008; 74: 7434-7436.
34. Ninomiya M, Takahashi M, Nishizawa T, Shimosegawa T, Okamoto H. Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy. Journal of Clinical Microbiology 2008; 46: 507-514.
35. Maggi F, Pifferi M, Fornai C, et al. TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. Journal of Virology 2003; 77: 2418-2425.
36. Maggi F, Andreoli E, Lanini L, et al. Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried. Journal of Clinical Microbiology 2005; 43: 4807-4810.
37. Kobayashi M, Chayama K, Arase Y, et al. Prevalence of TT virus before and after blood transfusion in patients with chronic liver disease treated surgically for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 1999; 14: 358-363.
38. Matsumoto A, Yeo AE, Shih JW, Tanaka E, Kiyosawa K, Alter HJ. Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology 1999; 30: 283-288.
39. Lefrere JJ, Roudot-Thoraval F, Lefrere F, et al. Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients. Blood 1999; 95: 347-351.
40. Pistello M, Morrica A, Maggi F, et al. TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathologies. Journal of Medical Virology 2001; 63: 189-195.
41. Maggi F, Bendinelli M. Immunobiology of the torque teno viruses and other anelloviruses. Current Topics in Microbiology and Immunology 2009; 331: 65-90.
42. Ball JK, Curran R, Berridge S, et al. TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types. The Journal of General Virology 1999; 80: 1759-1768.
43. Maggi F, Andreoli E, Lanini L, et al. Rapid increase in total torquetenovirus (TTV) plasma viremia load reveals an apparently transient superinfection by a TTV of a novel group 2 genotype. Journal of Clinical Microbiology 2006; 44: 2571-2574.
44. Maggi F, Pistello M, Vatteroni ML, et al. Dynamics of persistent TT virus infection, as estimated in patients treated with interferon-alpha for concomitant hepatitis C. Journal of Virology 2001; 75: 11999-12004.
45. Kikuchi K, Miyakawa H, Abe K, et al. Indirect evidence of TTV replication in bone marrow cells, but not in hepatocytes, of a subacute hepatitis/aplastic anemia patient. Journal of Medical Virology 2000; 61: 165-170.
46. Okamoto H, Takahashi M, Nishizawa T, et al. Replicative forms of TT virus DNA in bone marrow cells. Biochemical and Biophysical Research Communications 2000; 270: 657-662.
47. Okamoto H, Ukita M, Nishizawa T, et al. Circular double-stranded forms of TT virus DNA in the liver. Journal of Virology 2000; 74: 5161-5167.
48. Maggi F, Fornai C, Zaccaro L, et al. TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. Journal of Medical Virology 2001; 64: 190-194.
49. Maggi F, Pifferi M, Tempestini E, et al. TT virus loads and lymphocyte subpopulations in children. Journal of Virology 2003; 77: 9081-9083.
50. Kanda Y, Tanaka Y, Kami M, et al. TT virus in bone marrow transplant recipients. Blood 1999; 93: 2485-2490.
51. Maggi F, Focosi D, Albani M, et al. Role of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia. Journal of Virology 2010; 84: 6891-6893.
52. Okamoto H, Nishizawa T, Takahashi M, Asabe S, Tsuda F, Yoshikawa A. Heterogeneous distribution of TT virus of distinct genotypes in multiple tissues from infected humans. Virology 2001; 288: 358-368.
53. Peng YH, Nishizawa T, Takahashi M, Ishikawa T, Yoshikawa A, Okamoto H. Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Archives of Virology 2002; 147: 21-41.
54. Biagini P, Gallian P, Attoui H, et al. Genetic analysis of full-length genomes and subgenomic sequences of TT virus-like mini virus human isolates. The Journal of General Virology 2001; 82: 379-383.
55. Bendinelli M, Maggi F. TT virus and other anelloviruses. In Topley and Wilson-Microbiology and Microbial Infections, Mahy B, ter Meulen V (eds). E. Arnold Press: London, 2005; 1276-1283.
56. Andreoli E, Maggi F, Pistello M, et al. The novel anellovirus SAV is highly prevalent in hepatitis C patients and healthy controls and as diverse as the other two species of the genus, TTV and TTMV. Emerging Infectious Diseases 2006; 12: 1175-1176.
57. Moen EM, Sleboda J, Grinde B. Serum concentration of TT virus and TT virus-like mini virus in patients developing AIDS. AIDS 2002; 16: 1679-1682.
58. Biagini P, Gallian P, Cantaloube JF, Attoui H, de Micco P, de Lamballerie X. Distribution and genetic analysis of TTV and TTMV major phylogenetic groups in French blood donors. Journal of Medical Virology 2006; 78: 298-304.
59. Biagini P, de Micco P, de Lamballerie X. Identification of a third member of the Anellovirus genus ("small anellovirus") in French blood donors. Archives of Virology 2006; 151: 405-408.
60. Thom K, Petrik J. Progression towards AIDS leads to increased torque teno virus and torque teno minivirus titers in tissues of HIV infected individuals. Journal of Medical Virology 2007; 79: 1-7.
61. Okamoto H, Mayumi M. TT virus: virological and genomic characteristics and disease associations. Journal of Gastroenterology 2001; 36: 519-529.
62. Lin CL, Kyono W, Tongson J, et al. Fecal excretion of a novel human circovirus, TT virus, in healthy children. Clinical and Diagnostic Laboratory Immunology 2000; 7: 960-963.
63. Emre S, Otlu B, Cankaya C, Doganay S, Durmaz R. Transfusion-transmitted virus DNA in serum, tear and aqueous humour of patients undergoing cataract operation. Clinical and Experimental Ophthalmology 2007; 35: 759-762.
64. Osiowy C, Sauder C. Detection of TT virus in human hair and skin. Hepatology Research 2000; 16: 155-162.
65. Azzi A, Maggi F, Zakrzewska K, et al. Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification. Transfusion 2006; 46: 1162-1167.
66. Welch J, Bienek C, Gomperts E, Simmonds P. Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products. Transfusion 2006; 46: 1951-1958.
67. Verani M, Casini B, Battistini R, Pizzi F, Rovini E, Carducci A. One-year monthly monitoring of Torque teno virus (TTV) in river water in Italy. Water Science and Technology 2006; 54: 191-195.
68. Diniz-Mendes L, Paula VS, Luz SL, Niel C. High prevalence of human Torque teno virus in streams crossing the city of Manaus, Brazilian Amazon. Journal of Applied Microbiology 2008; 105: 51-58.
69. Griffin JS, Plummer JD, Long SC. Torque teno virus: an improved indicator for viral pathogens in drinking waters. Virology Journal 2008; 5: 112.
70. Haramoto E, Kitajima M, Katayama H, Ohgaki S. Real-time PCR detection of adenoviruses, polyomaviruses, and torque teno viruses in river water in Japan. Water Research 2010; 44: 1747-1752.
71. Leary TP, Erker JC, Chalmers ML, Desai SM, d Mushahwar IK. Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. The Journal of General Virology 1999; 80: 2115-2120.
72. Okamoto H, Takahashi M, Nishizawa T, et al. Genomic characterization of TT viruses (TTVs) in pigs, cats and dogs and their relatedness with species-specific TTVs in primates and tupaias. The Journal of General Virology 2002; 83: 1291-1297.
73. Hino S, Miyata H. Torque teno virus (TTV): current status. Reviews in Medical Virology 2007; 17: 45-57.
74. Devalle S, Niel C. Distribution of TT virus genomic groups 1-5 in Brazilian blood donors, HBV carriers, and HIV-1 infected patients. Journal of Medical Virology 2004; 72: 166-173.
75. Charlton M, Adjei P, Poterucha J, et al. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998; 28: 839-842.
76. Berg T, Schreier E, Heuft HG, et al. Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donors. Journal of Medical Virology 1999; 59: 117-121.
77. Tuveri R, Jaffredo F, Lunel F, et al. Impact of TT virus infection in acute and chronic, viral- and nonviral-related liver diseases. Journal of Hepatology 2000; 33: 121-127.
78. Shang D, Lin YH, Rigopoulou I, Chen B, Alexander GJ, Allain JP. Detection of TT virus DNA in patients with liver disease and recipients of liver transplant. Journal of Medical Virology 2000; 61: 455-461.
79. Sagir A, Kirschberg O, Heintges T, Erhardt A, Haussinger D. SEN virus infection. Reviews in Medical Virology 2004; 14: 141-148.
80. Nobili V, Maggi F, Marcellini M, Diciommo V, Caione D, Bendinelli M. Is torquetenovirus a potential cause of liver damage in children? The Journal of Infection 2005; 50: 368-369.
81. Piaggio F, Dodi F, Bottino G, et al. Torque teno virus-cause of viral liver disease following liver transplantation: a case report. Transplantation Proceedings 2009; 41: 1378-1379.
82. Ishimura M, Ohga S, Ichiyama M, et al. Hepatitis-associated aplastic anemia during a primary infection of genotype 1a torque teno virus. European Journal of Pediatrics 2010; 169: 899-902.
83. Sospedra M, Zhao Y, zur Hausen H, et al. Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PloS Pathogens 2005; 1: 335-348.
84. Tomasiewicz K, Modrzewska R, Lyczak A, Krawczuk G. TT virus infection and pancreatic cancer: relationship or accidental coexistence. World Journal of Gastroenterology 2005; 11: 2847-2849.
85. Guney C, Kadayifci A, Savas MC, Uygun A, Balkan A, Kubar A. Frequency of hepatitis G virus and transfusion-transmitted virus infection in type II diabetes mellitus. International Journal of Clinical Practice 2005; 59: 206-209.
86. Szladek G, Juhasz A, Kardos G, et al. High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma. Journal of Clinical Pathology 2005; 58: 402-405.
87. Zur Hausen H, de Villiers EM. Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas. International Journal of Cancer 2005; 115: 1-5.
88. Zhong S, Yeo W, Tang MW, et al. Gross elevation of TT virus genome load in the peripheral blood mononuclear cells of cancer patients. Annals of the New York Academy of Sciences 2001; 945: 84-92.
89. Figueiredo CP, Franz-Vasconcelos HC, Giunta G, et al. Detection of torque teno virus in Epstein-Barr virus positive and negative lymphnodes of patients with Hodgkin lymphoma. Leukemia & Lymphoma 2007; 48: 731-735.
90. Bando M, Takahashi M, Ohno S, et al. Torque teno virus DNA titre elevated in idiopathic pulmonary fibrosis with primary lung cancer. Respirology 2008; 13: 263-269.
91. Zur Hausen H, de Villiers EM. TT viruses: oncogenic or tumor-suppressive properties? Current Topics in Microbiology and Immunology 2009; 331: 109-116.
92. Feher E, Gall T, Murvai M, et al. Investigation of the occurrence of torque tenovirus in malignant and potentially malignant disorders associated with human papillomavirus. Journal of Medical Virology 2009; 81: 1975-1981.
93. Rotundo R, Maggi F, Nieri M, Muzzi L, Bendinelli M, Prato GP. TT virus infection of periodontal tissues: a controlled clinical and laboratory pilot study. Journal of Periodontology 2004; 75: 1216-1220.
94. Maggi F, Andreoli E, Riente L, et al. Torquetenovirus in patients with arthritis. Rheumatology 2007; 46: 885-886.
95. Biagini P, Charrel RN, de Micco P, de Lamballerie X. Association of TT virus primary infection with rhinitis in a newborn. Clinical Infectious Diseases 2003; 36: 128-129.
96. Pifferi M, Maggi F, Andreoli E, et al. Relationships between nasal TT virus burdens and spirometric indices in asthmatic children. Journal of Infectious Diseases 2005; 192: 1141-1148.
97. Pifferi M, Maggi F, Caramella D, et al. High torquetenovirus loads are correlated with bronchiectasis and peripheral airflow limitation in children. The Pediatric Infectious Disease Journal 2006; 25: 804-808.
98. Christensen JK, Eugen-Olsen J, Sorensen M, et al. Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus. Journal of Infectious Diseases 2000; 81: 1796-1799.
99. Shibayama T, Masuda G, Ajisawa A, et al. Inverse relationship between the titre of TT virus DNA and CD4 cell count in patients infected with HIV. AIDS 2001; 15: 563-570.
100. Sagir A, Adams O, Antakyali M, et al. SEN virus has an adverse effect on the survival of HIV-positive patients. AIDS 2005; 19: 1091-1096.
101. Maggi F, Ricci V, Bendinelli M, et al. Changes in CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia. Transplantation 2008; 85: 1867-1868.
102. Devalle S, Rua F, Morgado MG, Niel C. Variations in the frequencies of torque teno virus subpopulations during HAART treatment in HIV-1-coinfected patients. Archives in Virology 2009; 154: 1285-1291.
103. Focosi D, Maggi F, Albani M, et al. Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution. Journal of Clinical Virology 2010; 47: 189-192.
104. Kanda Y, Hirai H. TT virus in haematological disorders and bone marrow transplant recipients. Leukemia & Lymphoma 2001; 40: 483-489.
105. Yokoyama H, Yasuda J, Okamoto H, Iwakura Y. Pathological changes of renal epithelial cells in mice transgenic for the TT virus ORF1 gene. Journal of General Virology 2002; 83: 141-150.
106. Simmonds P. TT virus infection: a novel virus-host relationship. Journal of Medical Microbiology 2002; 51: 455-458.
107. Usta M, Dilek K, Ersoy A, et al. Prevalence of transfusion transmitted virus infection and its effect on renal graft survival in renal transplant recipients. Scandinavian Journal of Urology and Nephrology 2002; 36: 473-477.
108. Szladek G, Juhasz A, Asztalos L, et al. Persisting TT virus (TTV) genogroup 1 variants in renal transplant recipients. Archives in Virology 2003; 148: 841-851.
109. Davidson I, Shulman LM. Unraveling the puzzle of human anellovirus infections by comparison with avian infections with the chicken anemia virus. Virus Research 2008; 137: 1-15.
110. De Villiers EM, Zur Hausen H (eds). TT viruses: the still elusive human pathogens. In Current Topics in Microbiology and Immunology. Springer-Verlag: Berlin, 2009; 1-230.
111. Mushahwar IK. Recently discovered blood-borne viruses: are they hepatitis viruses or merely endosymbionts? Journal of Medical Virology 2000; 62: 399-404.
112. Rocchi J, Ricci V, Albani M, et al. Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9. Virology 2009; 394: 235-242.
113. Bendinelli M, Bonis PA. TT and other anelloviruses. In UpToDate, Rose BD (ed.). Wolters Kluwer Health. Headquarter: Alphen aan den Rijn, the Netherlands, 2007.
114. Specter S, Bendinelli M, Friedman H (eds). Neuropathogenic Viruses and Immunity. Plenum Press: New York, NY, 1992; 1-353.
115. Schneider-Schaulies J, Schneider-Schaulies S, ter Meulen V. Infections of the central nervous system. In Topley and Wilson-Microbiology and Microbial Infections, Mahy B, ter Meulen V (eds). E. Arnold Press: London, 2005; 1403-1442.
116. Grinde B. Is chronic fatigue syndrome caused by a rare brain infection of a common, normally benign virus? Medical Hypotheses 2008; 71: 270-274.
117. Maggi F, Fornai C, Vatteroni ML, et al. Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders. Journal of Medical Virology 2001; 65: 418-422.
118. Pollicino T, Raffa G, Squadrito G, et al. TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. Journal of Viral Hepatitis 2003; 10: 95-102.
119. Shiramizu B, Yu Q, Hu N, Yanagihara R, Nerurkar VR. Investigation of TT virus in the etiology of pediatric acute lymphoblastic leukemia. Pediatric Hematology and Oncology 2002; 19: 543-551.
120. Dix RD, McCarthy M, Berger JR. Diagnostic value for culture of cerebrospinal fluid from HIV-1 infected individuals for opportunistic viruses: a prospective study. AIDS 1994; 8: 307-312.
121. Maggi F, Giorgi M, Fornai C, et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. Journal of Neurovirology 1999; 5: 319-323.
122. Grigoriadis N, Hadjigeorgou GM. Virus-mediated autoimmunity in multiple sclerosis. Journal of Autoimmune Diseases 2006; 3: 1-8.
123. Giovannoni G, Cutter GR, Lunemann J, et al. Infectious causes of multiple sclerosis. Lancet Neurology 2006; 5: 887-894.
124. Libbey JE, Fujinami RS. Potential triggers of MS. Results and Problems in Cell Differentiation 2010; 1-22. DOI: 10.1007/400_2008_12
125. Kuhle J, Pohl C, Mehling M, et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. The New England Journal of Medicine 2007; 356: 371-378.
126. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002; 59: 371-378.
127. Rafnsson SB, Deary IJ, Smith FB, et al. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh artery study. Journal of the American Geriatrics Society 2007; 55: 700-707.
128. Laurin D, David Curb J, Masaki KH, White LR, Launer LJ. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiology of Aging 2009; 30: 1724-1727.
129. Marioni RE, Strachan MW, Reynolds RM, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes 2010; 59: 710-713.
130. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatrics Society 2006; 54: 1046-1054.
131. Wiss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature Medicine 2006; 12: 1005-1015.